Pediatrix Medical Group (NYSE:MD) Upgraded at StockNews.com

StockNews.com upgraded shares of Pediatrix Medical Group (NYSE:MD) from a hold rating to a buy rating in a research note published on Wednesday morning.

Other analysts also recently issued reports about the company. Mizuho raised their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Jefferies Financial Group lifted their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Truist Financial dropped their price objective on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating on the stock in a report on Monday, January 6th. UBS Group lifted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $16.25.

Pediatrix Medical Group Trading Up 1.0 %

NYSE MD opened at $14.30 on Wednesday. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of -4.67, a PEG ratio of 1.42 and a beta of 1.58. The business’s fifty day moving average is $14.00 and its 200-day moving average is $12.03. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $16.41.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million for the quarter, compared to analysts’ expectations of $498.87 million. During the same period in the previous year, the company earned $0.29 earnings per share. The company’s quarterly revenue was up .9% on a year-over-year basis. Equities research analysts predict that Pediatrix Medical Group will post 1.26 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the transaction, the executive vice president now directly owns 135,810 shares in the company, valued at approximately $2,172,960. This represents a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total transaction of $423,660.00. Following the sale, the director now owns 138,683 shares of the company’s stock, valued at approximately $2,128,784.05. The trade was a 16.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Pediatrix Medical Group

Several institutional investors and hedge funds have recently made changes to their positions in MD. Quest Partners LLC lifted its position in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after buying an additional 622 shares during the last quarter. Quarry LP lifted its holdings in shares of Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after acquiring an additional 1,662 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at $72,000. CWM LLC grew its holdings in shares of Pediatrix Medical Group by 134.0% during the 3rd quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after purchasing an additional 3,681 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC purchased a new position in Pediatrix Medical Group in the 2nd quarter worth $81,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.